Keywords: amylin/, lilly, plan, byetta, monotherapy, filing, drug

Amylin/ lilly plan Byetta monotherapy filing

Article | 17 December 2007

Print This

US drug firms Amylin Pharmaceuticals and Eli Lilly say that data from a study examining the antidiabetic Byetta (exenatide), as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in